These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 21141806

  • 1. Functionalized cyclic RGD peptidomimetics: conjugable ligands for αvβ3 receptor imaging.
    Arosio D, Manzoni L, Araldi EM, Caprini A, Monferini E, Scolastico C.
    Bioconjug Chem; 2009 Aug 19; 20(8):1611-7. PubMed ID: 21141806
    [Abstract] [Full Text] [Related]

  • 2. Cyclic RGD functionalized gold nanoparticles for tumor targeting.
    Arosio D, Manzoni L, Araldi EM, Scolastico C.
    Bioconjug Chem; 2011 Apr 20; 22(4):664-72. PubMed ID: 21434651
    [Abstract] [Full Text] [Related]

  • 3. Specific detection of integrin αvβ3 by light-up bioprobe with aggregation-induced emission characteristics.
    Shi H, Liu J, Geng J, Tang BZ, Liu B.
    J Am Chem Soc; 2012 Jun 13; 134(23):9569-72. PubMed ID: 22642547
    [Abstract] [Full Text] [Related]

  • 4. Determination of the binding epitope of RGD-peptidomimetics to αvβ3 and α(IIb)β3 integrin-rich intact cells by NMR and computational studies.
    Guzzetti I, Civera M, Vasile F, Araldi EM, Belvisi L, Gennari C, Potenza D, Fanelli R, Piarulli U.
    Org Biomol Chem; 2013 Jun 21; 11(23):3886-93. PubMed ID: 23657523
    [Abstract] [Full Text] [Related]

  • 5. Multivalent cyclic RGD ligands: influence of linker lengths on receptor binding.
    Kubas H, Schäfer M, Bauder-Wüst U, Eder M, Oltmanns D, Haberkorn U, Mier W, Eisenhut M.
    Nucl Med Biol; 2010 Nov 21; 37(8):885-91. PubMed ID: 21055618
    [Abstract] [Full Text] [Related]

  • 6. Cyclic RGD β-lactam peptidomimetics induce differential gene expression in human endothelial cells.
    Aizpurua JM, Ganboa JI, Palomo C, Loinaz I, Oyarbide J, Fernandez X, Balentová E, Fratila RM, Jiménez A, Miranda JI, Laso A, Avila S, Castrillo JL.
    Chembiochem; 2011 Feb 11; 12(3):401-5. PubMed ID: 21290542
    [No Abstract] [Full Text] [Related]

  • 7. The role of adhesion molecules, alpha v beta 3, alpha v beta 5 and their ligands in the tumor cell and endothelial cell adhesion.
    Niu JX, Zhang WJ, Ye LY, Wu LQ, Zhu GJ, Yang ZH, Grau GE, Lou JN.
    Eur J Cancer Prev; 2007 Dec 11; 16(6):517-27. PubMed ID: 18090124
    [Abstract] [Full Text] [Related]

  • 8. Cyclic RGD peptidomimetics containing bifunctional diketopiperazine scaffolds as new potent integrin ligands.
    Marchini M, Mingozzi M, Colombo R, Guzzetti I, Belvisi L, Vasile F, Potenza D, Piarulli U, Arosio D, Gennari C.
    Chemistry; 2012 May 14; 18(20):6195-207. PubMed ID: 22517378
    [Abstract] [Full Text] [Related]

  • 9. Cyclic RGD peptidomimetics containing 4- and 5-amino-cyclopropane pipecolic acid (CPA) templates as dual αVβ3 and α5β1 integrin ligands.
    Sernissi L, Trabocchi A, Scarpi D, Bianchini F, Occhiato EG.
    Bioorg Med Chem; 2016 Feb 15; 24(4):703-11. PubMed ID: 26753814
    [Abstract] [Full Text] [Related]

  • 10. Multimodality tumor imaging targeting integrin alphavbeta3.
    Cai W, Sam Gambhir S, Chen X.
    Biotechniques; 2005 Dec 15; 39(6 Suppl):S14-25. PubMed ID: 20158499
    [Abstract] [Full Text] [Related]

  • 11. Structure-activity relationships of 111In- and 99mTc-labeled quinolin-4-one peptidomimetics as ligands for the vitronectin receptor: potential tumor imaging agents.
    Harris TD, Kalogeropoulos S, Nguyen T, Dwyer G, Edwards DS, Liu S, Bartis J, Ellars C, Onthank D, Yalamanchili P, Heminway S, Robinson S, Lazewatsky J, Barrett J.
    Bioconjug Chem; 2006 Dec 15; 17(5):1294-313. PubMed ID: 16984141
    [Abstract] [Full Text] [Related]

  • 12. Antiangiogenic effect of dual/selective alpha(5)beta(1)/alpha(v)beta(3) integrin antagonists designed on partially modified retro-inverso cyclotetrapeptide mimetics.
    Gentilucci L, Cardillo G, Spampinato S, Tolomelli A, Squassabia F, De Marco R, Bedini A, Baiula M, Belvisi L, Civera M.
    J Med Chem; 2010 Jan 14; 53(1):106-18. PubMed ID: 20055426
    [Abstract] [Full Text] [Related]

  • 13. Probing for integrin alpha v beta3 binding of RGD peptides using fluorescence polarization.
    Wang W, Wu Q, Pasuelo M, McMurray JS, Li C.
    Bioconjug Chem; 2005 Jan 14; 16(3):729-34. PubMed ID: 15898744
    [Abstract] [Full Text] [Related]

  • 14. αvβ3-Integrin-targeting lanthanide complex: synthesis and evaluation as a tumor-homing luminescent probe.
    Ito T, Inoue M, Akamatsu K, Kusaka E, Tanabe K, Nishimoto S.
    Bioorg Med Chem Lett; 2011 Jun 15; 21(12):3515-8. PubMed ID: 21600766
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Heterophilic interactions between cell adhesion molecule L1 and alphavbeta3-integrin induce HUVEC process extension in vitro and angiogenesis in vivo.
    Hall H, Djonov V, Ehrbar M, Hoechli M, Hubbell JA.
    Angiogenesis; 2004 Jun 15; 7(3):213-23. PubMed ID: 15609076
    [Abstract] [Full Text] [Related]

  • 17. Multiphoton-absorption-induced-luminescence (MAIL) imaging of tumor-targeted gold nanoparticles.
    Dowling MB, Li L, Park J, Kumi G, Nan A, Ghandehari H, Fourkas JT, DeShong P.
    Bioconjug Chem; 2010 Nov 17; 21(11):1968-77. PubMed ID: 20964333
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Up-regulation of alphavbeta3 integrin expression is a novel molecular response to chemotherapy-induced cell damage in a heregulin-dependent manner.
    Vellon L, Menendez JA, Liu H, Lupu R.
    Differentiation; 2007 Nov 17; 75(9):819-30. PubMed ID: 17999741
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.